FDA Guidance for Industry: Regulatory Classification of Pharmaceutical Co-Crystals

Titel:
FDA Guidance for Industry: Regulatory Classification of Pharmaceutical Co-Crystals
Herkunft/Verlag:

FDA, https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM281764.pdf

Inhalt:
This guidance provides applicants planning to submit new drug applications (NDAs) and abbreviated new drug applications (ANDAs) with information on the appropriate regulatory classification of pharmaceutical co-crystal solid-state forms

Zurück

GMP Seminare nach Thema